Showing results (791-800 of 833) with videos related to
Sort By:
Pageof 84
Journal of Alzheimer'S Disease : JAD|April 1, 2016
Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic MouseMiguel Ángel Ontiveros-Torres, María Luisa Labra-Barrios, Sofía Díaz-Cintra, et al.Journal of Alzheimer'S Disease : JAD|June 16, 2020
Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's DiseaseMario Hernandes-Alejandro, Sarita Montaño, Charles R Harrington, et al.Ageing Research Reviews|April 29, 2026
Serious Side Effects of Alzheimer's Immunotherapy Demand ScrutinyPoul F Høilund-Carlsen, Abass Alavi, Sasan Andalib, et al.Journal of Alzheimer'S Disease : JAD|April 11, 2022
Making the Case for Accelerated Withdrawal of AducanumabPeter Whitehouse, Sam Gandy, Vikas Saini, et al.Journal of Alzheimer'S Disease : JAD|November 2, 2016
Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau PathologyRachel H L H Rueli, Daniel J Torres, Andrea S T Dewing, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 7, 2023
Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaborationRichard Lathe, Nikki M Schultek, Brian J Balin, et al.The Journal of Biological Chemistry|March 16, 2005
Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active ironKazuhiro Honda, Mark A Smith, Xiongwei Zhu, et al.Current Alzheimer Research|September 22, 2017
Evaluation of Metabolic and Synaptic Dysfunction Hypotheses of Alzheimer's Disease (AD): A Meta-Analysis of CSF MarkersRoni Manyevitch, Matthew Protas, Sean Scarpiello, et al.Acta Neuropathologica|August 13, 2005
Redox metals and oxidative abnormalities in human prion diseasesRobert B Petersen, Sandra L Siedlak, Hyoung-gon Lee, et al.Journal of Diabetes and Its Complications|March 13, 2026
Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort studyAnderson Matheus Pereira da Silva, Leonardo Januário Campos Cardoso, Sávio Batista, et al.Pageof 84